Article: ALK-Abello: New Tablet-Based Immunotherapy for Grass Allergy Approved.

HEyRSHOLM, Denmark, March 16 /PRNewswire/ --

- The Swedish Medical Products Agency has Approved ALK-Abello's Tablet-Based Immunotherapy, GRAZAX(R), for the Treatment of Grass Pollen Allergy. ALK-Abello will now Submit Applications for GRAZAX(R) in Other European Countries Using the Mutual Recognition Procedure

ALK-Abello's tablet-based immunotherapy, GRAZAX(R), has been approved by the Swedish Medical Products Agency for the treatment of grass pollen allergy.

ALK-Abello will now submit further applications in other European countries via the Mutual Recognition Procedure. ALK-Abello still expects GRAZAX(R) to be launched in the first European markets by the end ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!